Legal Opinion
Cancer Research Technology Limited and Schering v. Barr Laboratories
Court of Appeals for the Federal Circuit
Decided November 9, 2010No. 2010-1204PublishedCited by 32 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge LOURIE, in which Circuit Judge NEWMAN joins. Dissenting opinion filed by Circuit Judge PROST.
LOURIE, Circuit Judge.
Cancer Research Technology Limited and Schering Corporation (collectively, “Cancer Research”) appeal from the final decision of the United States District Court for the District of Delaware holding U.S. Patent 5,260,291 (“the '291 patent”) unenforceable for prosecution laches and inequitable conduct. Cancer Research Tech. v. Barr Labs., Inc., 679 F.Supp.2d 560 (D.Del.2010). We reverse.
Background
The '291 patent claims a genus of…
2Cases cited15 opinions
- A.C. Aukerman Company v. R.L. Chaides Construction Co.Court of Appeals for the Federal Circuit · 1992
- Star Scientific, Inc. v. R.J. Reynolds Tobacco Co.Court of Appeals for the Federal Circuit · 2008
- Critikon, Inc., Plaintiff-Cross v. Becton Dickinson Vascular Access, Inc.Court of Appeals for the Federal Circuit · 1997
- General Talking Pictures Corp. v. Western Electric Co.Supreme Court of the United States · 1938
- Ipxl Holdings, L.L.C. v. Amazon.com, Inc.Court of Appeals for the Federal Circuit · 2005
10 more not listed; retrieve them via the Exa API.
3Cited by32 opinions
- Maling v. Finnegan, Henderson, Farabow, Garrett & Dunner, LLPMassachusetts Supreme Judicial Court · 2015
- Chamberlain Group, Inc. v. Lear Corp.District Court, N.D. Illinois · 2010
- Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd.District Court, E.D. Michigan · 2011
- Hyatt v. IancuCourt of Appeals for the D.C. Circuit · 2018
- In Re Cyclobenzaprine HydrochlorideDistrict Court, D. Delaware · 2011
27 more not listed; retrieve them via the Exa API.